Iatrogenic thyrotoxicosis: Causal circumstances, pathophysiology, and principles of treatment - Review of the literature

World Journal of Surgery

Volumn 24, Issue 11, 2000, Pages 1377-1385

  Meurisse, Michel ^a   Gollogly, Laragh ^a   Degauque, Cyrille ^a   Fumal, Isabelle ^a   Defechereux, Thierry ^a   Hamoir, Etienne ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIINFECTIVE AGENT; CONTRAST MEDIUM; LITHIUM; THYROID HORMONE;

CELL DAMAGE; CONFERENCE PAPER; CYTOTOXICITY; DISEASE SEVERITY; HUMAN; HYPERTHYROIDISM; IRRADIATION; LYMPHOCYTIC INFILTRATION; PATHOPHYSIOLOGY; SUBACUTE THYROIDITIS; THYROID HORMONE BLOOD LEVEL; THYROTOXICOSIS;

AMIODARONE; ANIMALS; CYTOKINES; FEMALE; HUMANS; IATROGENIC DISEASE; IODIDES; IODINE RADIOISOTOPES; LITHIUM; MALE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; THYROIDECTOMY; THYROTOXICOSIS;

EID: 0033773995     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002680010228     Document Type: Conference Paper

References (120)

1. Lithium associated thyrotoxicosis: A report of 14 cases, with statistical analysis of incidence
2. Lithium associated thyrotoxicosis
3. Lithium-induced thyroid disorders: A prevalence study
4. Antithryoid effects of lithium
5. Lithium-associated thyroid disease: A report of 14 cases of hypothyroidism and 4 cases of thyrotoxicosis
6. Serum thyrotropin and thyroxin concentrations in patients receiving lithium carbonate
7. The effects of lithium therapy on parameters thought to be involved in the development of autoimmune thyroid disease
8. The enhancement of immunoglobulin synthesis by human lymphocytes with lithium
9. Histological features of the thyroid gland in a patient with lithium induced thyrotoxicosis
10. Exophthalmos and elevated thyroxine levels in association with lithium therapy
11. Thyrotoxicosis developing during lithium treatment: Case report
12. Thyrotoxicosis during lithium treatment
13. Asymptomatic Graves' disease during lithium therapy
14. Lithium as an adjunct to radioiodine therapy for thyrotoxicosis
15. Incidence rate and risks factors for thyroid dysfunction during recombinant interleukin-2 therapy in advanced malignancies
16. Thyroid dysfunction following IL-2 therapy
17. Thyroid dysfunction associated with immunotherapy for patients with cancer
18. Thyroiditis after treatment with interleukin-2 and interferon α-2a
19. Effects of recombinant human interleukin-2 and tumor necrosis factor-α with or without interferon-γ on human thyroid tissues from patients with Graves' disease and from normal subjects xenografted into nude mice
20. Autoimmunity and thyroid function in patients with chronic active hepatitis treated by recombinant interferon alpha-2a
21. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon alpha
22. Suppression of HLA class II expression on thyrocytes by interferon alpha
23. 125I incorporation and thyroid hormone release by human thyroid follicules in vitro
24. Thyroid function abnormalities associated with the chronic outpatient administration of recombinant interleukin-2 and recombinant interferonalpha
25. Autoimmune thyroid disease: Further developments in our understanding
26. Interferon alpha induced thyroid dysfunction: Three clinical presentations and review of the literature
27. Seat belt-related thyroiditis documented with thyroid Tc-99m pertechnctate scans
28. Martial arts thyroiditis
29. Transient thyroiditis due to surgical trauma
30. Thyrotoxicosis after needle aspiration of thyroid cyst
31. Postparathyroidectomy transient thyrotoxicosis
32. Palpation thyroiditis (multifocal granulomatous folliculitis)
33. Treatment of non toxic multinodular goiter with radioactive iodine
34. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters
35. 131I therapy
36. 131I treatment in patients with nontoxic goiter
37. Natural heterogeneity of thyroid cells: The basis for understanding thyroid function and nodular growth
38. Hyperfunc tioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary adenoma
39. Effect of irradiation on the thyroid-autoantibody production
40. Autoimmune thyroiditis: Predisposition and pathogenesis
41. Graves' disease induced by radioactive iodine
42. Painless thyroiditis with hyperthyroidism following external irradiation of the neck
43. Hypothyroidism and Graves' disease after mantle irradiation: A follow-up study
44. Ophthalmopathy following external neck irradiation for nonthyroidal neoplastic disease
45. Effect of irradiation on thyroid autoantibody production
46. Occult factitial thyrotoxicosis
47. Thyrotoxicosis of extrathyroid origin
48. The cardiovascular manifestations of induced thyrotoxicosis; report of two cases
49. Thyrotoxicosis due to ingestion of excess thyroid hormone
50. Plasmapheresis in L-thyroxine intoxication
51. Clinical observations on thyroidismus medicamentosus due to weight reducing pills in Japan
52. An outbreak of thyrotoxicosis caused by the consumption of bovine thyroid gland in ground beef
53. Community outbreak of thyrotoxicosis: Epidemiology, immunogenetic characteristics, and long-term outcome
54. Accidental ingestion of poisons
55. Serum iodine of cuthyroid subject treated with desiccated thyroid
56. Sudden death associated with thyroid hormone abuse
57. 1983 Annual report of the American Association of Poison Control Centers national data collection system
58. Massive levothyroxine overdose: High anxiety-low toxicity
59. Plasmapheresis in thyroxine overdose: A case report
60. Thyrotoxicosis after a single ingestion of levothyroxine
61. Accidental poisoning with thyroid extract treated by exchange transfusion
62. Minor signs and symptoms of toxicity in a young woman in spite of massive thyroxine ingestion
63. Triiodothyroxine intoxication
64. Low serum thyroglobulin as a clue to thc diagnosis of thyrotoxicosis factitia
65. Pathways of metabolism of thyroid hormones
66. Use of sodium ipodate in management of hyperthyroidism in subacute thyroiditis
67. Acute L-thyroxine overdose; therapy with sodium ipodate: Evaluation of clinical and physiologic parameters
68. Effect of drugs on thyroid function
69. Roentgenographic contrast agents inhibit triiodothyronine binding to nuclear receptors in vitro
70. Plasma inorganic iodide as homeostatic regulator of thyroid function
71. The temporary nature, of the inhibitory action of excess iodide on organic iodine synthesis in the normal thyroid
72. Iodide-induced thyrotoxicosis
73. Natural course of iodine-induced thyrotoxicosis (Jodbasedow) in endemic goiter area: A 5-year follow-up
74. Bread: A dietary source of large quantities of iodine
75. Iodine absorption in burn patients treated topically with povidone-iodine
76. Syndromes of thyrotoxicosis with low radioactive iodine uptake
77. Therapeutic aspects of iodine4nduced thyrotoxicosis
78. Effects of amiodarone on thyroid function
79. A consensus report on antiarrhythmic drug use
80. Effects of amiodarone on mortality after myocardial infarction: A double-blind, placebo-controlled, pilot study
81. Amiodarone in chronic heart failure
82. Thyroid dysfunction during chronic amiodarone therapy
83. Amiodarone and thyroid function
84. Pharmacology of amiodarone, an anti-anginal drug with a new biological profile
85. Effect of excess iodide: Clinical aspects
86. Iodine kinetic studies during amiodarone treatment
87. The effects of amiodarone on thyroid hormone function: A review of the physiology and clinical manifestations
88. Recherches dans la scrie des benzofuranes. XXXVII. Etude comparee du transit et du metabolisme de l'amiodarone chez diverses especes animales et chez l'homme
89. Amiodarone: Historical development and pharmacology profiles
90. Amiodarone and the thyroid
91. Amiodaronc-induced thyrotoxicosis
92. Amiodarone-induced hyperthyroidism: Thyroidectomy under local anesthesia
93. Amiodarone: A common source of iodine-induced thyrotoxicosis
94. Amiodarone-induced thyrotoxicosis: Is there a place for surgery?
95. Lifethreatening thyrotoxicosis induced by amiodarone in patients with benign heart disease
96. Fatal hyperthyroidism after amiodarone treatment and total lymphoid irradiation in a heart transplant recipient
97. Iodine-induced thyrotoxicosis: Analysis of eighty-five consecutive cases
98. Failure to respond to dexamethasone with fatal consequences, after initial response to multidrug treatment in a case of amiodarone-associated thyrotoxicosis
99. Rapid effectiveness of prednisone and thionamides combined therapy in severe amiodarone iodine-induced thyrotoxicosis: Comparison of two groups of patients with apparently normal glands
100. Hyperthyroidies severes induites par l'iode: Une urgence chirurgicale
101. The effects of amiodarone on serum thyroid hormones and hepatic thyroxine 5'-monodeiodination in rats
102. Treatment of amiodarone induced thyrotoxicosis, a difficult challenge: Results of a prospective study
103. Pathology of the thyroid gland in amiodarone-associated thyrotoxicosis
104. Serum interleukin-6 in amiodarone-induced thyrotoxicosis
105. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis
106. Surgical management of amiodarone-associated thyrotoxicosis: Too risky or too effective?
107. Amiodarone and the thyroid: A practical guide to the management of thyroid dysfunction induced by amiodarone therapy
108. Amiodarone-associated thyrotoxicosis (AAT): Experience with surgical management
109. Thyroidectomy for amiodarone-induced thyrotoxicosis
110. Amiodarone: The dilemma of hyperthyroxinaemia and the treatment of thyrotoxicosis
111. Thyrotoxicose severe et surcharge iodee: Apropos d'un cas d'evolution mortelle
112. Ten years of experience with amiodarone
113. Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment
114. Iodine treatment of iodine induced thyrotoxicosis
115. Effects of propylthiouracil and relatively small doses of iodine on early phase treatment of hyperthyroidism?
116. Fatal aplastic anemia after treatment of thyrotoxicosis with potassium perchlorate
117. The effects of plasmapheresis on thyroid hormone and plasma drug concentrations in amiodarone-induced thyrotoxicosis
118. Failure of plasmapheresis, corticosteroids and thionamides to ameliorate a case of proctated amiodarone-induced thyroiditis
119. Amiodarone-induced thyrotoxocosis: Clinical presentation and expanded indications for thyroidectomy
120. Anaesthetic management of the paturient receiving amiodarone